Carmat
Jean-Luc Lemercier draws on more than 20 years’ experience and acknowledged leadership in medical devices. During his career, he has held a number of key positions in the field of cardiology, notably at Johnson & Johnson Cordis from 1996 to 2008, where he created and headed the Structural Heart Disease division. Since 2008, he has been Corporate Vice President EMEA, Canada & Latin America at Edwards Lifescience.
Mr Lemercier graduated in pharmacy from Claude Bernard Lyon 1 University.
He first joined the Carmat Board of Directors on 24 April 2017.
This person is not in the org chart
This person is not in any offices
Carmat
CARMAT is a medical device company developing the world’s most advanced total artificial heart. CARMAT aims to eventually provide a response to a major public health issue associated with heart disease, the world’s leading cause of death: chronic and acute heart failure.